Virtu Financial LLC Guardant Health, Inc. Transaction History

Virtu Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$21.58 - $29.5 $186,019 - $254,290	8,620 New	8,620 $233,000
Q1 2023 May 01, 2023	SELL	$22.92 - $33.76 $193,628 - $285,204	-8,448 Reduced 48.83%	8,853 $207,000
Q4 2022 Feb 15, 2023	BUY	$25.44 - $59.78 $440,137 - $1.03 Million	17,301 New	17,301 $471,000
Q1 2021 May 19, 2021	SELL	$127.04 - $179.1 $492,915 - $694,908	-3,880 Closed	0 $0
Q4 2020 Feb 24, 2021	SELL	$99.96 - $135.93 $432,127 - $587,625	-4,323 Reduced 52.7%	3,880 $500,000
Q3 2020 Dec 11, 2020	BUY	$80.32 - $111.8 $658,864 - $917,095	8,203 New	8,203 $917,000
Q2 2020 Aug 07, 2020	SELL	$60.49 - $97.5 $390,281 - $629,070	-6,452 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$59.49 - $82.78 $220,350 - $306,617	-3,704 Reduced 36.47%	6,452 $504,000
Q3 2019 Nov 20, 2019	BUY	$62.59 - $110.3 $635,664 - $1.12 Million	10,156 New	10,156 $648,000
Q2 2019 Aug 13, 2019	SELL	$63.94 - $91.11 $374,368 - $533,449	-5,855 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$34.3 - $97.98 $200,826 - $573,672	5,855 New	5,855 $449,000

349

115M

793K

1.85M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.41B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.